Key result
In patients with atrial fibrillation and cardiac resynchronization therapy, appropriate antithromboembolic prophylaxis and rate/rhythm control, including AV node ablation, are needed to maximize outcomes.
Why the study?
What are the optimal clinical management strategies for atrial fibrillation in patients with cardiac resynchronization therapy?
What are the optimal clinical management strategies for atrial fibrillation in patients with cardiac resynchronization therapy?
In patients with CRT and AF, appropriate anticoagulation and rate/rhythm control, particularly AV node ablation, are crucial to ensure continuous biventricular pacing.
Answers are grounded in this paper and cite their sources.
Supports anticoagulation and AV nodal ablation to maximize CRT efficacy in AF; leaves open need for randomized confirmation.
VASc scores. In summary, in order to maximise outcome, AF in patients with CRT prompts the need to appropriately decide on antithromboembolic prophylaxis (according to risk stratifications), as well as on rate and/or rhythm control strategies, with the aim to allow constant biventricular pacing. In this perspective, AVN ablation has an important role since by inducing pace-maker dependency guarantees continuous biventricular pacing.
No takes yet. Share an insight, caveat, or question.
Boriani et al. (2013) conducted a review in Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy. Clinical management (antithromboembolic prophylaxis, rate/rhythm control, AVN ablation) was evaluated. In patients with atrial fibrillation and cardiac resynchronization therapy, appropriate antithromboembolic prophylaxis and rate/rhythm control, including AV node ablation, are needed to maximize outcomes.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: